GEMMINAR
LIVE

Serial Number

98040605

Owner

Vanda Pharmaceuticals Inc.

Attorney

Jayme M. Torelli

Filing Date

Jun 13, 2023

Add to watchlist:

No watchlists yet
View on USPTO

GEMMINAR Trademark

Serial Number: 98040605

GEMMINAR is a trademark filed by Vanda Pharmaceuticals Inc. on June 13, 2023. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Vanda Pharmaceuticals Inc. (97 trademarks)

Suite 300
Rockville, MD 20850

Entity Type: 03

Trademark Details

Filing Date

June 13, 2023

Registration Date

Not Registered

Published for Opposition

December 19, 2023

Goods & Services

Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the treatment and prevention of motion sickness; Pharmaceutical preparations for the treatment and prevention of cravings for opioid substances or opiate substances; Pharmaceutical preparations for the treatment and prevention of nausea; Pharmaceutical preparations for the treatment and prevention of vomiting; Pharmaceutical preparations for the treatment and prevention of substance dependence; Pharmaceutical preparations for the treatment and prevention of anxiety; Pharmaceutical preparations for the treatment and prevention of diseases, disorders, or conditions caused by an over-expression of the neuropeptide known as substance P; Pharmaceutical preparations for the treatment and prevention of diseases, disorders, or conditions caused by overstimulation of the neurokinin-1 (NK-1) receptor; Pharmaceutical preparations for the treatment of gastroparesis; Pharmaceutical preparations for the treatment of pruritus; Pharmaceutical preparations for the treatment of atopic dermatitis; Pharmaceutical preparations for the treatment of pain; Pharmaceutical preparations for the treatment of psychiatric diseases and disorders; Pharmaceutical preparations for treating epidermal problems; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 29, 2026 EXRA
SOU EXTENSION 4 GRANTED
Jan 28, 2026 EX4G
SOU EXTENSION 4 FILED
Jan 28, 2026 EXT4
SOU TEAS EXTENSION RECEIVED
Jan 28, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 28, 2025 EXRA
SOU EXTENSION 3 GRANTED
Jun 27, 2025 EX3G
SOU EXTENSION 3 FILED
Jun 27, 2025 EXT3
SOU TEAS EXTENSION RECEIVED
Jun 27, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 3, 2025 EXRA
SOU EXTENSION 2 GRANTED
Jan 3, 2025 EX2G
SOU EXTENSION 2 FILED
Jan 3, 2025 EXT2
SOU TEAS EXTENSION RECEIVED
Jan 2, 2025 EEXT
SOU EXTENSION 1 GRANTED
Aug 1, 2024 EX1G
SOU EXTENSION 1 FILED
Aug 1, 2024 EXT1
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 31, 2024 EXRA
SOU TEAS EXTENSION RECEIVED
Jul 31, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Feb 13, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 19, 2023 NPUB
PUBLISHED FOR OPPOSITION
Dec 19, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 29, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 16, 2023 CNSA
ASSIGNED TO EXAMINER
Nov 13, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 17, 2023 NWOS
NEW APPLICATION ENTERED
Jun 16, 2023 NWAP